Skip to main content
OpenTrials

Clinical trial condition

Heredodegenerative Disorders, Nervous System

Explore clinical trials studying Heredodegenerative Disorders, Nervous System. Study availability and eligibility vary by location and protocol.

1,877 public trials 411 recruiting studies
Refine in advanced search Browse all conditions

Heredodegenerative Disorders, Nervous System trial results

Completed

Neuroimaging of Dystonia

NCT02046447

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +18 more
Locations
  • University of Florida Gainesville, Florida, United States
View Trial Details
Completed

Single Dose Pharmacokinetic (PK) Study

NCT03109756

Conditions
Abnormalities, Multiple, Angelman Syndrome, Central Nervous System Diseases, +15 more
Locations
  • Ovid Therapeutics Investigative Site Chicago, Illinois, United States
  • Ovid Therapeutics Investigative Site Nashville, Tennessee, United States
View Trial Details
Completed

Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A

NCT01401257

Conditions
Charcot-Marie-Tooth Disease, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations
  • Hôpital Roger Salengro Lille, France
  • CHU Dupuytren Limoges, France
  • CHU Lyon Sud Lyon, France
  • Hôpital La Timone Marseille, France
View Trial Details
Completed

A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas

NCT00634270

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Chicago Chicago, Illinois, United States
  • National Cancer Institute (NCI) Bethesda, Maryland, United States
View Trial Details
Completed

Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease

NCT02197130

Conditions
Basal Ganglia Diseases, Behavior, Behavioral Symptoms, +19 more
Locations
  • The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
View all 57 locations
View Trial Details

Related conditions